Recent News

By Category: Research

UTMB Collaborates on Program Targeting Potential Bioterrorist Pathogens

(Global Biodefense) The University of Texas Medical Branch at Galveston, Profectus Biosciences, Tekmira Pharmaceuticals and the Vanderbilt University Medical Center have been awarded up to $26 million to advance treatments of the highly lethal hemorrhagic fever viruses Ebola and Marburg. These filoviruses are considered “Tier 1″ pathogens by the U.S. Department of Health and Human Read More »

March 11, 2014
| Filed under Agents & Toxins, Bioterrorism, Countermeasures, and Research
Share

Emerging multi-drug resistant infections lack standard definition and treatment

(EurekAlert) Infection control practices for detecting and treating patients infected with emerging multidrug-resistant gram-negative bacteria (MDR-GNB) vary significantly between hospitals. A study from the Society for Healthcare Epidemiology of America Research Network, a consortium of more than 200 hospitals collaborating on multi-center research projects, found this inconsistency could be contributing to the increase in multidrug-resistant Read More »

March 11, 2014
| Filed under Agents & Toxins, Public Health, and Research
Share

FDA grants ‘fast track designation’ to Tekmira to develop Ebola drug – The Global Dispatch

March 11, 2014
| Filed under Biosafety and Research
Share

FDA grants ‘fast track designation’ to Tekmira to develop Ebola drug

(The Global Dispatch) Canadian pharmaceutical company, Tekmira Pharmaceuticals Corporation announced Wednesday that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of TKM-Ebola, an anti-Ebola viral therapeutic. The FDA’s Fast Track is a process designed to facilitate the development and expedite the review of drugs to treat serious conditions Read More »

March 11, 2014
| Filed under Biosafety, Countermeasures, and Research
Share

Notre Dame chemists discover new class of antibiotics

(Notre Dame News) A team of University of Notre Dame researchers led by Mayland Chang and Shahriar Mobashery have discovered a new class of antibiotics to fight bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and other drug-resistant bacteria that threaten public health. Their research is published in the Journal of the American Chemical Society in Read More »